Dibutyl phthalate (DBP) promotes Epithelial-Mesenchymal Transition (EMT) to aggravate liver fibrosis into cirrhosis and portal hypertension (PHT) via ROS/TGF-β1/Snail-1 signalling pathway in adult rats
Open Access
- 18 March 2024
- journal article
- research article
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 274, 116124
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 71 references indexed in Scilit:
- Rebalancing TGF‐β/Smad7 signaling via Compound kushen injection in hepatic stellate cells protects against liver fibrosis and hepatocarcinogenesisClinical and Translational Medicine, 2021
- Animal models of portal hypertensionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2019
- Epithelial-to-mesenchymal transition in cancer: complexity and opportunitiesFrontiers of Medicine, 2018
- High regenerative capacity of the liver and irreversible injury of male reproductive system in carbon tetrachloride-induced liver fibrosis rat modelEPMA Journal, 2017
- Mouse and Rat Models of Induction of Hepatic Fibrosis and Assessment of Portal Hypertension2017
- Advanced oxidation protein products induce hepatocyte epithelial–mesenchymal transition via a ROS‐dependent, TGF‐β/Smad signaling pathwayCell Biology International, 2017
- EMT and inflammation: inseparable actors of cancer progressionMolecular Oncology, 2017
- Pathophysiology of Portal HypertensionClinics in Liver Disease, 2014
- Proteome-Wide Analyses of Human Hepatocytes During Differentiation and DedifferentiationHepatology, 2013
- The Hyperdynamic Circulation of Chronic Liver Diseases: From the Patient to the MoleculeHepatology, 2006